Last reviewed · How we verify

Ferric Maltol (Feraccru®) — Competitive Intelligence Brief

Ferric Maltol (Feraccru®) (Ferric Maltol (Feraccru®)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iron supplement. Area: Hematology.

marketed Iron supplement Iron (Fe³⁺) delivery via maltol chelation Hematology Small molecule Live · refreshed every 30 min

Target snapshot

Ferric Maltol (Feraccru®) (Ferric Maltol (Feraccru®)) — Pharmanutra S.p.a.. Ferric maltol is an iron-carbohydrate complex that provides bioavailable iron to treat iron deficiency anemia by replenishing iron stores.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ferric Maltol (Feraccru®) TARGET Ferric Maltol (Feraccru®) Pharmanutra S.p.a. marketed Iron supplement Iron (Fe³⁺) delivery via maltol chelation
ferrous fumarate with ascorbic acid ferrous fumarate with ascorbic acid Pharmacosmos A/S marketed Iron supplement with vitamin C enhancer
Orifer F® Orifer F® The Hospital for Sick Children marketed Iron supplement with folic acid
Treatment with oral sucrosomial iron Treatment with oral sucrosomial iron University of Rochester marketed Iron supplement (oral formulation) Iron (Fe3+) absorption pathway
F (ferrous sulphate) F (ferrous sulphate) Abdelwahed, Mai Mahmoud Mohamed, M.D. marketed Iron supplement Iron (Fe2+) for hemoglobin and myoglobin synthesis
TOT'HEMA TOT'HEMA Laboratoire Innotech International marketed Iron supplement
Fisiogen Ferro Forte Fisiogen Ferro Forte Hospital Universitari Vall d'Hebron Research Institute marketed Iron supplement Iron (Fe2+/Fe3+)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iron supplement class)

  1. Tanabe Pharma Corporation · 4 drugs in this class
  2. Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri · 2 drugs in this class
  3. Universidade Federal Fluminense · 2 drugs in this class
  4. Clinica Fabia Mater · 1 drug in this class
  5. GlaxoSmithKline · 1 drug in this class
  6. Hatem AbuHashim · 1 drug in this class
  7. Hospital Universitari Vall d'Hebron Research Institute · 1 drug in this class
  8. Laboratoire Innotech International · 1 drug in this class
  9. Lee's Pharmaceutical Limited · 1 drug in this class
  10. Milton S. Hershey Medical Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ferric Maltol (Feraccru®) — Competitive Intelligence Brief. https://druglandscape.com/ci/ferric-maltol-feraccru. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: